University of California San Diego researchers have discovered the enzyme responsible for chromothripsis, a process in which ...
Patent Protects Novel Application of Gedeptin Therapy Across Multiple Solid Tumor Types; Supports Expansion of Gedeptin ...
Phase 1/2 Trial Confirms Safety With Repeated Dosing Supporting Further Development in Early-stage Disease and Combination Treatment Settings ATLANTA, GA - December 8, 2025 (NEWMEDIAWIRE) - GeoVax ...
Mycosis fungoides, the most prevalent CTCL subtype, accounts for the majority of cases. Although early-stage disease has a five-year survival rate of roughly 88%, it is a chronic cancer with ...
As big pharmas including Takeda and Novo Nordisk flee the cell therapy space and smaller biotechs shutter their operations, ...
Objectives In high-income countries hepatitis E virus (HEV) is an uncommonly diagnosed porcine-derived zoonoses. After identifying disproportionate chronic HEV infections in persons with cystic ...
The regulator has received reports that a group of patients treated with Adzynma had neutralizing antibodies against the protein the therapy replaces. The FDA is investigating adverse events, ...
aDepartment of Rheumatology and Immunology, National Key Laboratory of Immunity and Inflammation, Changhai Hospital, Naval Medical University, Shanghai, China bDepartment of Rheumatology, Peking Union ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback